Embolic Protection Devices

Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices | September 18, 2017

September 18, 2017 – Claret Medical announced publication of a new study in the...

Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices | September 07, 2017

September 7, 2017 — Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection...

PinnacleHealth First in Pennsylvania to Implant Sentinel Cerebral Protection System
News | Embolic Protection Devices | August 23, 2017

August 23, 2017 — PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to...

FDA clears Claret Medical Sentinel embolic protection device for TAVR
Feature | Heart Valve Technology | June 09, 2017

June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel ...

Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System
News | Peripheral Artery Disease (PAD) | May 17, 2017

May 17, 2017 — Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral...

PinnacleHealth Initiates Clinical Study of TriGuard Embolic Protection Device
News | Embolic Protection Devices | April 11, 2017

April 11, 2017 — Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an...

Cardiogard embolic protection system for surgical valve reaplacement

The CardioGard embolic protection system for surgical aortic valve replacement.

Feature | Embolic Protection Devices | March 22, 2017

March 22, 2017 — Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove...

Claret Medical Sentinel Cerebral Protection System (CPS), FDA, TAVR embolic protection, transcatheter aortic valve replacement (TAVR).
News | Heart Valve Technology | February 28, 2017

February 28, 2017 — A U.S. Food and Drug Administration (FDA) panel has recommended market clearance for the Claret...

InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid | November 18, 2016

November 18, 2016 — InspireMD Inc. announced in mid-October the online publication of positive clinical data in a...

Videos | Heart Valve Technology | November 08, 2016

Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage...

TAVR, post-procedure, brain lesions, delirium, TCT 2016, Peter R. Stella
News | Heart Valve Technology | November 07, 2016

November 7, 2016 — Keystone Heart Ltd. announced that data presented at the Transcatheter Cardiovascular...

Sentinel, TAVR, TAVI, embloic protection
News | Heart Valve Technology | November 07, 2016

November 7, 2016 – A multicenter randomized trial evaluating the role of embolic protection using the Sentinel...

Keystone Heart, TriGuard Embolic Protection Device, real-world results, PCR London Valves Conference 2016
News | Embolic Protection Devices | September 29, 2016

September 29, 2016 — Keystone Heart Ltd. recently announced the safety and efficacy of the TriGuard Cerebral...

Claret Medical, Sentinal CPS, cerebral protection system, FDA marketing application, TAVR, embolic protection
News | Embolic Protection Devices | September 20, 2016

September 20, 2016 – Claret Medical announced its filing of a marketing application with the U.S. Food and Drug...

Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman

The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.

Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell

Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater...

Overlay Init